FDA approves new U.S. labeling for ISENTRESS® (raltegravir)
New U.S. labeling for ISENTRESS® (raltegravir) to include 240-week results…
1 July 2013 | By Merck
New U.S. labeling for ISENTRESS® (raltegravir) to include 240-week results from STARTMRK study...